Press release


Belgium—February 11, 2013.

Ontex IV S.A. (“Ontex”), Europe’s leading manufacturer of private-label hygienic disposable products, announces the signing of the acquisition of Artsana Sud S.p.A. (“Serenity”), a leading manufacturer and distributor of incontinence products in Italy, from Artsana Group and the offering of €75 million 7.5% Senior Secured Notes due 2018 by Senior 1 S.A., a société anonyme incorporated under the laws of Luxembourg (the “ Temporary Notes”), to finance, in part, the acquisition. The consummation of the acquisition is subject to certain conditions.

Pending closing of the acquisition of Serenity, the proceeds of the Temporary Notes offering will be deposited into an escrow account. Upon completion of the acquisition, the Temporary Notes will be automatically exchanged for additional notes (the “Additional Notes”) to be issued by Ontex under the indenture dated March 31, 2011, pursuant to which Ontex issued its existing €320 million 7.5% Senior Secured Notes due 2018 and €280 million Senior Secured Floating Rate Notes due 2018.

Ontex will use the gross proceeds of this offering, together with cash on hand, to (i) purchase the issued and outstanding capital stock of Serenity and (ii) pay certain fees and expenses associated with the acquisition of Serenity and the offering of Temporary Notes.

Additional information concerning recent developments in Ontex’s business will be set out in a report to be posted today on Ontex’s website.

For further information, please contact:Investor Relations
Severine Camp +(44) 20 7614 2900
[email protected]

Important Regulatory Notice
This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The Temporary Notes and Additional Notes mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “Securities Act”). The Temporary Notes and Additional Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. There will be no public offer of the Temporary Notes or the Additional Notes in the United States.

This press release may include projections and other “forward-looking” statements within the meaning of applicable securities laws. Any such projections or statements reflect the current views of the Company about further events and/or financial performance. No assurances can be given that such events or performance will occur as projected, and actual results may differ materially from these projections.

This announcement is being distributed only to, and is directed at (a) persons who have professional experience in matters relating to investments who fall within Article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (b) high net worth entities, and other persons to whom it may otherwise lawfully be communicated, falling within Article 49(1) of the Order (all such persons together being referred to as “relevant persons”). The investments to which this announcement relates are available only to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such investments will be available only to or will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents. Persons distributing this announcement must satisfy themselves that it is lawful to do so.

Neither the content of Ontex’s website nor any website accessible by hyperlinks on Ontex’s website is incorporated in, or forms part of, this announcement. The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.


Maarten Verbanck

Phone: +32 53 33 36 20

Geoffroy Raskin